The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dennehy, K. M.
Right arrow Articles by Hünig, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dennehy, K. M.
Right arrow Articles by Hünig, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2006, 176: 5725-5729.
Copyright © 2006 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Monovalency of CD28 Maintains the Antigen Dependence of T Cell Costimulatory Responses1

Kevin M. Dennehy*,{dagger}, Fernando Elias*, Gabrielle Zeder-Lutz{ddagger}, Xin Ding§, Danièle Altschuh{ddagger}, Fred Lühder* and Thomas Hünig2,*

* Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany; {dagger} Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa; {ddagger} Unité Mixte de Recherche 7175, Centre National de la Recherche Scientifique, Ecole Supérieure de Biotechnologie de Strasbourg, Illkirch, France; § TeGenero Immunotherapeutics, Würzburg, Germany; and Institut für Multiple Sklerose Forschung, Göttingen, Germany

CD28 and CTLA-4 are the major costimulatory receptors on naive T cells. But it is not clear why CD28 is monovalent whereas CTLA-4 is bivalent for their shared ligands CD80/86. We generated bivalent CD28 constructs by fusing the extracellular domains of CTLA-4 or CD80 with the intracellular domains of CD28. Bivalent or monovalent CD28 constructs were ligated with recombinant ligands with or without TCR coligation. Monovalent CD28 ligation did not induce responses unless the TCR was coligated. By contrast, bivalent CD28 ligation induced responses in the absence of TCR engagement. To extend these findings to primary cells, we used novel superagonistic and conventional CD28 Abs. Superagonistic Ab D665, but not conventional Ab E18, predominantly ligates CD28 bivalently at low CD28/Ab ratios and induces Ag-independent T cell proliferation. Monovalency of CD28 for its natural ligands is thus essential to provide costimulation without inducing responses in the absence of TCR engagement.




This article has been cited by other articles:


Home page
BloodHome page
N. Beyersdorf, X. Ding, T. Hunig, and T. Kerkau
Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease
Blood, November 12, 2009; 114(20): 4575 - 4582.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Beyersdorf, X. Ding, G. Blank, K. M. Dennehy, T. Kerkau, and T. Hunig
Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody
Blood, November 15, 2008; 112(10): 4328 - 4336.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. A. Teft and J. Madrenas
Molecular Determinants of Inverse Agonist Activity of Biologicals Targeting CTLA-4
J. Immunol., September 15, 2007; 179(6): 3631 - 3637.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Dennehy, F. Elias, S.-Y. Na, K.-D. Fischer, T. Hunig, and F. Luhder
Mitogenic CD28 Signals Require the Exchange Factor Vav1 to Enhance TCR Signaling at the SLP-76-Vav-Itk Signalosome
J. Immunol., February 1, 2007; 178(3): 1363 - 1371.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.